Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease

ISSN： 1479-6678

Source： Future Cardiology, Vol.6, Iss.5, 2010-09, pp. : 657-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptors as therapeutic targets in inflammation

By Plutzky J.

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1764-1766

Elsevier

Access to resources Recommend Favorite

Dual Peroxisome Proliferator-Activated Receptor-α/ Agonists: In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Pershadsingh Harrihar A.

Treatments in Endocrinology, Vol. 5, Iss. 2, 2006-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus

Current Diabetes Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 33-39

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphism in the peroxisome proliferator‐activated receptor‐ gene in women with polycystic ovary syndrome

By Korhonen S.

Human Reproduction, Vol. 18, Iss. 3, 2003-03 ,pp. : 540-543

Oxford University Press

Access to resources Recommend Favorite